VCG
GSK icon

Vantage Consulting Group’s GSK GSK Stock Holding History

Vantage Consulting Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-434
Closed -$20K – 702
2020
Q4 		$20K Buy
+434
New +$19.9K ﹤0.01% 867

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Vantage Consulting Group's GSK Position: Q1 2021 in Review

Vantage Consulting Group sold out of GSK (GSK) in Q1 2021, closing a stake of 434 shares — an estimated $20K sold.

Vantage Consulting Group first reported a position in GSK in Q4 2020 and held it in 1 quarter. The position peaked at $20K in Q4 2020. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

  • Vantage Consulting Group reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 434 GSK shares in Q1 2021, an estimated $20K.
  • Vantage Consulting Group first reported a position in GSK in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's GSK position peaked at $20K in Q4 2020.
  • 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.